Candida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral
cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial …

The incidence of fungal infections has increased significantly, so contributing to morbidity
and mortality. This is caused by an increase in antimicrobial resistance and the restricted …

Monoclonal antibodies are widely used for the treatment of cancer, inflammatory and
infectious diseases and other disorders. Most of the marketed antibodies are monospecific …

The importance of the microbiome to human health is increasingly recognized and has
become a major focus of recent research. However, much of the work has focused on a few …

Candida species belong to the normal microbiota of the oral cavity and gastrointestinal and
vaginal tracts, and are responsible for several clinical manifestations, from mucocutaneous …

An evaluation of studies of biologically active nanoparticles provides guidance for the
synthesis of nanoparticles with the goal of develo** new antibiotics/antifungals to combat …

Infectious diseases constitute an increasing threat to public health and medical systems
worldwide. Particularly, the emergence of multidrug-resistant pathogens has left the …

Infections caused by Candida species have been increasing in the last decades and can
result in local or systemic infections, with high morbidity and mortality. After Candida …

The association between Candida albicans (C. albicans) and cancer has been noticed for
decades. Whether C. albicans infection is a complication of cancer status or as a contributor …

Fungi are major causes of infections among immunocompromised or hospitalized patients
with serious underlying diseases and comorbidities. Candida species remain the most …